These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31943042)

  • 1. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.
    Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis.
    Mills DJ; Lau CL; Mills C; Furuya-Kanamori L
    J Travel Med; 2022 Mar; 29(2):. PubMed ID: 34875078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-visit Intradermal Rabies Postexposure Vaccination.
    Soentjens P; De Koninck K; Tsoumanis A; Herssens N; Van Den Bossche D; Terryn S; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Aug; 69(5):797-804. PubMed ID: 30566636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic.
    Lau C; Sisson J
    J Travel Med; 2002; 9(6):285-8. PubMed ID: 12962581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial.
    Overduin LA; Koopman JPR; Prins C; Verbeek-Menken PH; De Pijper CA; Eblé PL; Heerink F; van Genderen PJJ; Grobusch MP; Visser LG
    Lancet Infect Dis; 2024 Feb; 24(2):206-216. PubMed ID: 37802090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.
    Lau CL; Hohl N
    Travel Med Infect Dis; 2013; 11(6):427-30. PubMed ID: 24135254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation.
    Kewcharoenwong C; Freeouf S; Nithichanon A; Petsophonsakul W; Pornprasert S; Khamduang W; Suzuki T; Onodera T; Takahashi Y; Lertmemongkolchai G
    Med Microbiol Immunol; 2024 May; 213(1):7. PubMed ID: 38761268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.
    Soentjens P; Andries P; Aerssens A; Tsoumanis A; Ravinetto R; Heuninckx W; van Loen H; Brochier B; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Feb; 68(4):607-614. PubMed ID: 29939243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers.
    Mills DJ; Lau CL; Mills C; Furuya-Kanamori L
    J Travel Med; 2021 Jul; 28(5):. PubMed ID: 33837774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
    Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
    J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
    Quiambao BP; Lim JG; Bosch Castells V; Augard C; Petit C; Bravo C; Delore V; Houillon G
    Vaccine; 2022 Aug; 40(36):5347-5355. PubMed ID: 35933278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the immune response after a double-dose 2-visit pre-exposure rabies intradermal vaccination schedule: A retrospective study.
    Damanet B; Costescu Strachinaru DI; Soentjens P
    Travel Med Infect Dis; 2020; 33():101554. PubMed ID: 31931134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Memory Response After a Single Intramuscular Rabies Booster Vaccination 10-24 Years After Primary Immunization.
    De Pijper CA; Langedijk AC; Terryn S; Van Gucht S; Grobusch MP; Goorhuis A; Stijnis C
    J Infect Dis; 2022 Sep; 226(6):1052-1056. PubMed ID: 33502530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response after rabies pre-exposure prophylaxis and a booster dose in Australian bat carers.
    Guo Y; Mills DJ; Lau CL; Mills C; Furuya-Kanamori L
    Zoonoses Public Health; 2023 Sep; 70(6):465-472. PubMed ID: 37170441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule--a case series of 420 travelers.
    Mills DJ; Lau CL; Fearnley EJ; Weinstein P
    J Travel Med; 2011; 18(5):327-32. PubMed ID: 21896096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial.
    Garcia Garrido HM; van Put B; Terryn S; de Pijper CA; Stijnis C; D'Haens GR; Spuls PI; van de Sande MG; van Gucht S; Grobusch MP; Goorhuis A
    J Travel Med; 2023 Apr; 30(2):. PubMed ID: 36477981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.